Similar articles

• Core outcomes for subarachnoid haemorrhage.

  Andersen CR, Presseau J, Saigle V, Etminan N, Vergouwen MDI, English SW; Outcomes in Subarachnoid Haemorrhage Working Group. Andersen CR, et al. Lancet Neurol. 2019 Dec;18(12):1075-1076. doi: 10.1016/S1474-4422(19)30412-0. Lancet Neurol. 2019. PMID: 31701889 No abstract available.
• NeuroNEXT: accelerating drug development in neurology.

  The Lancet Neurology. The Lancet Neurology. Lancet Neurol. 2012 Feb;11(2):119. doi: 10.1016/S1474-4422(12)70008-X. Lancet Neurol. 2012. PMID: 22265207 No abstract available.
• Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference.

  Sieber BA, Landis S, Koroshetz W, Bateman R, Siderowf A, Galpern WR, Dunlop J, Finkbeiner S, Sutherland M, Wang H, Lee VM, Orr HT, Gwinn K, Ludwig K, Taylor A, Torborg C, Montine TJ; Parkinson's Disease 2014: Advancing Research, Improving Lives Conference Organizing Committee. Sieber BA, et al. Ann Neurol. 2014 Oct;76(4):469-72. doi: 10.1002/ana.24261. Epub 2014 Sep 23. Ann Neurol. 2014. PMID: 25164235 Free PMC article. No abstract available.
• FDA: evidentiary standards for drug development and approval.

  Katz R. Katz R. NeuroRx. 2004 Jul;1(3):307-16. doi: 10.1602/neurorx.1.3.307. NeuroRx. 2004. PMID: 15717032 Free PMC article. Review.
• A common data language for clinical research studies: the National Institute of Neurological Disorders and Stroke and American Academy for Cerebral Palsy and Developmental Medicine Cerebral Palsy Common Data Elements Version 1.0 recommendations.

  Schiariti V, Fowler E, Brandenburg JE, Levey E, Mcintyre S, Sukal-Moulton T, Ramey SL, Rose J, Sienko S, Stashinko E, Vogtle L, Feldman RS, Koenig JI. Schiariti V, et al. Dev Med Child Neurol. 2018 Oct;60(10):976-986. doi: 10.1111/dmcn.13723. Epub 2018 Mar 15. Dev Med Child Neurol. 2018. PMID: 29542813 Review.